MedTrace Logo

Genetic Factors on Outcomes of Kidney Transplant Patients With Tacrolimus-based Therapy

NCT03764670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2021-03-12

No results posted yet for this study

Summary

The purpose of this study is to identify the influence of genetic and clinical factors on the clinical outcomes of kidney transplant patients with tacrolimus (TAC) based immunosuppression in Taiwan.

Conditions

  • Kidney Transplantation

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Meng-Kun Tsai, Professor · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-30
Primary Completion
2019-10-03
Completion
2020-09-22

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03764670 on ClinicalTrials.gov